Bayer Cash on Hand 2012-2025 | BAYRY | MacroTrends

Bayer Cash on Hand 2012-2025 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer cash on hand for the quarter ending December 31, 2025 was $9.121B, a 0.33% decline year-over-year.

Bayer cash on hand for 2025 was $9.121B, a 0.33% decline from 2024.
Bayer cash on hand for 2024 was $9.151B, a 21.29% decline from 2023.
Bayer cash on hand for 2023 was $11.627B, a 6.33% increase from 2022.

Bayer Cash on Hand 2012-2025 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer cash on hand for 2025 was $9.121B, a 0.33% decline from 2024.
Bayer cash on hand for 2024 was $9.151B, a 21.29% decline from 2023.
Bayer cash on hand for 2023 was $11.627B, a 6.33% increase from 2022.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$887.6B
Johnson & Johnson (JNJ)	$574.4B
AbbVie (ABBV)	$367.7B
Roche Holding AG (RHHBY)	$318.8B
Merck (MRK)	$299.9B
Novartis AG (NVS)	$294B
Novo Nordisk (NVO)	$167.5B
Pfizer (PFE)	$153.1B
Sanofi (SNY)	$114B
Innoviva (INVA)	$1.8B